Rotterdam- Start of the 2nd Dutch trial site

On 15 July  2026, the Erasmus MC in Rotterdam, Nerherlands  became officially a trial site of the STOP-PKD Study.

Dr. Mahdi Salih´s team cares for patients with a wide range of nephrological issues, including those affected by autosomal dominant polycystic kidney disease (ADPKD).

Interested patients can now make an appointment at the trial site in Rotterdam to obtain detailed information about the trial and potential participation.

Phone: 

Email:   STOP.PKD@erasmusmc.nl